GlassScriptPhysician profile
Shanda Haley Blackmon
NPI 1952347965
$37,689.37
in general payments reported to CMS, 2019-2025
10 companies · $757 in 2025
The $757 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,714 · 2020: $13K · 2021: $5,270 · 2022: $4,801 · 2023: $2,092 · 2024: $2,032 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Grant: $1,790 · Food and Beverage: $774 · Travel and Lodging: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Grant | $1,790.08 |
| Food and Beverage | $773.95 |
| Travel and Lodging | $516.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $13,839.22 | 2019-2020 | |
| Medtronic, INC. | $11,754.78 | 2021-2023 | Avalus |
| Olympus Corporation | $6,223.01 | 2019 | |
| Medical Device Business Services, INC. | $2,656.25 | 2019 | |
| Medela LLC | $1,800.00 | 2024 | Art. 101030215 Thopaz+ Chest Drainage |
| Intuitive Surgical, INC. | $805.58 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $489.68 | 2023-2025 | Tagrisso |
| Genentech USA, INC. | $80.06 | 2024 | Alecensa |
| Cvrx, INC. | $20.89 | 2025 | Barostim Neo System |
| Ethicon US, LLC | $19.90 | 2024 | Echelon Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Blackmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.